Catalyst Wire Dossier Catalyst Wire Dossier

Romiplostim

romiplostim · Amgen
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for Romiplostim, covering 2009-09-18 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA [Phase 2]

See pricing